Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
14159 Capital , Llc Insider Profile
4 Followers
14159 Capital , Llc, Director, Ten Percent Owner at Incyte Corp, holds 83.53K shares in Ocera Therapeutics (Ticker: OCRX), holds 227.84K shares in Genomic Health (Ticker: GHDX), holds 360.23K shares in Xoma Corp (Ticker: XOMA). Most recently, 14159 Capital , Llc Bought ― shares of Ocera Therapeutics on Mar 14, 2012 for an estimated value of 81.04K.
14159 Capital , Llc Incyte Corp (INCY)Director, Ten Percent Owner
Incyte Corp (INCY)
Director, Ten Percent Owner
Ranked #11 out of 40,795 Corporate Insiders
Profitable Transactions
44 out of 67 Profitable Transactions
Average Return
+71.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
14159 Capital , Llc does not currently own shares as a corporate insider.
A breakdown of 14159 Capital , Llc's holdings
Insider Roles
Roles that 14159 Capital , Llc holds in companies
Most Profitable Insider Trade
Stock:
Pharmacyclics
(PCYC)
(PCYC)
Rating:Informative Buy
Date:Aug 24, 2011 - Aug 24, 2012
Return:+524.90%
The most profitable trade made by 14159 Capital , Llc
14159 Capital , Llc's Trading History
Incyte Corp
Jan 17, 2012
Director, Ten Percent Owner
Informative Buy
239.33K
$26.54M
Seattle Genetics
Sep 08, 2011
Director, Ten Percent Owner
Informative Buy
30.28K
$23.75M
Genomic Health
Mar 09, 2012
Director, Ten Percent Owner
Informative Buy
33.08K
$12.24M
Heron Therapeutics
Oct 28, 2009
Ten Percent Owner
Informative Buy
―
$13.16M
BioCryst
Jun 01, 2009
Ten Percent Owner
Informative Sell
66.89K
$938.31K
Ocera Therapeutics
Mar 14, 2012
Ten Percent Owner
Informative Buy
81.04K
―
Xoma Corp
Mar 08, 2012
Ten Percent Owner
Informative Buy
―
$528.73K
Idera
―
Ten Percent Owner
―
$30.31K
Auxilium
Aug 03, 2011
―
Informative Sell
307.08K
$5.06M
Pharmacyclics
Jan 26, 2012
―
Informative Buy
234.10K
$51.17M
Synageva
Jan 09, 2012
―
Uninformative Buy
732.46K
$32.40M
Tranzyme Inc
―
―
―
$199.73K
Viropharma
May 08, 2009
―
Informative Buy
―
$7.85M
List of latest transactions for each holding click on a transaction to see 14159 Capital , Llc's performance on stock
You May Also Like
14159 Capital , Llc insider profile FAQ
What is the percentage of profitable transactions made by 14159 Capital , Llc?
The percentage of profitable transactions made by 14159 Capital , Llc is 66%.
What is the average return per transaction made by 14159 Capital , Llc?
The average return per transaction made by 14159 Capital , Llc is 71.60%.
What stocks does 14159 Capital , Llc hold?
14159 Capital , Llc holds: INCY, SGEN, GHDX, HRTX, BCRX, OCRX, XOMA, IDRA, AUXL, PCYC, GEVA, DEL_TZYM, VPHM stocks.
What was 14159 Capital , Llc’s latest transaction?
14159 Capital , Llc latest transaction was an Informative Buy of 81.04K.
What was 14159 Capital , Llc's most profitable transaction?
14159 Capital , Llc’s most profitable transaction was an Informative Buy of PCYC stock on August 24, 2011. The return on the trade was 524.90%.
What is 14159 Capital , Llc's role in Incyte Corp?
14159 Capital , Llc's role in Incyte Corp is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.